[Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 16, n. 4, p. 93–102, 2015. DOI: 10.7175/fe.v16i4.1221. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1221. Acesso em: 29 dec. 2025.